Colonial Trust Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,000
Closed -$919 773
2024
Q2
$919 Hold
1,000
﹤0.01% 702
2024
Q1
$454 Hold
1,000
﹤0.01% 916
2023
Q4
$560 Hold
1,000
﹤0.01% 813
2023
Q3
$660 Buy
+1,000
New +$689 ﹤0.01% 805

Other funds holding TLSA

Colonial Trust Advisors's TLSA Position: Q3 2024 in Review

Colonial Trust Advisors sold out of Tiziana Life Sciences (TLSA) in Q3 2024, closing a stake of 1,000 shares — an estimated $919 sold.

Colonial Trust Advisors first reported a position in TLSA in Q3 2023 and held it in 4 quarters. The position peaked at $919 in Q2 2024. 30 funds tracked by Wall St. Rank hold TLSA as of Q3 2024.

  • Colonial Trust Advisors reported no remaining Tiziana Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 1,000 Tiziana Life Sciences shares in Q3 2024, an estimated $919.
  • Colonial Trust Advisors first reported a position in Tiziana Life Sciences in Q3 2023 and held it in 4 quarters.
  • Colonial Trust Advisors's Tiziana Life Sciences position peaked at $919 in Q2 2024.
  • 30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q3 2024.

Based on Colonial Trust Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.